IBDEI0JA ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8677,0)
;;=D68.0^^39^401^213
;;^UTILITY(U,$J,358.3,8677,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8677,1,3,0)
;;=3^Von Willebrand's Disease
;;^UTILITY(U,$J,358.3,8677,1,4,0)
;;=4^D68.0
;;^UTILITY(U,$J,358.3,8677,2)
;;=^127267
;;^UTILITY(U,$J,358.3,8678,0)
;;=C88.0^^39^401^214
;;^UTILITY(U,$J,358.3,8678,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8678,1,3,0)
;;=3^Waldenstrom Macroglobulinemia
;;^UTILITY(U,$J,358.3,8678,1,4,0)
;;=4^C88.0
;;^UTILITY(U,$J,358.3,8678,2)
;;=^5001748
;;^UTILITY(U,$J,358.3,8679,0)
;;=C91.02^^39^401^3
;;^UTILITY(U,$J,358.3,8679,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8679,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,8679,1,4,0)
;;=4^C91.02
;;^UTILITY(U,$J,358.3,8679,2)
;;=^5001764
;;^UTILITY(U,$J,358.3,8680,0)
;;=C92.02^^39^401^6
;;^UTILITY(U,$J,358.3,8680,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8680,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Relapse
;;^UTILITY(U,$J,358.3,8680,1,4,0)
;;=4^C92.02
;;^UTILITY(U,$J,358.3,8680,2)
;;=^5001791
;;^UTILITY(U,$J,358.3,8681,0)
;;=D09.3^^39^401^50
;;^UTILITY(U,$J,358.3,8681,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8681,1,3,0)
;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
;;^UTILITY(U,$J,358.3,8681,1,4,0)
;;=4^D09.3
;;^UTILITY(U,$J,358.3,8681,2)
;;=^5001955
;;^UTILITY(U,$J,358.3,8682,0)
;;=C22.0^^39^401^91
;;^UTILITY(U,$J,358.3,8682,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8682,1,3,0)
;;=3^Hepatocellular Carcinoma
;;^UTILITY(U,$J,358.3,8682,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,8682,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,8683,0)
;;=C24.9^^39^401^118
;;^UTILITY(U,$J,358.3,8683,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8683,1,3,0)
;;=3^Malig Neop Biliary Tract,Unspec
;;^UTILITY(U,$J,358.3,8683,1,4,0)
;;=4^C24.9
;;^UTILITY(U,$J,358.3,8683,2)
;;=^5000942
;;^UTILITY(U,$J,358.3,8684,0)
;;=C50.922^^39^401^142
;;^UTILITY(U,$J,358.3,8684,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8684,1,3,0)
;;=3^Malig Neop Left Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,8684,1,4,0)
;;=4^C50.922
;;^UTILITY(U,$J,358.3,8684,2)
;;=^5133340
;;^UTILITY(U,$J,358.3,8685,0)
;;=C34.91^^39^401^160
;;^UTILITY(U,$J,358.3,8685,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8685,1,3,0)
;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
;;^UTILITY(U,$J,358.3,8685,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,8685,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,8686,0)
;;=C50.921^^39^401^164
;;^UTILITY(U,$J,358.3,8686,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8686,1,3,0)
;;=3^Malig Neop Right Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,8686,1,4,0)
;;=4^C50.921
;;^UTILITY(U,$J,358.3,8686,2)
;;=^5001198
;;^UTILITY(U,$J,358.3,8687,0)
;;=C90.02^^39^401^176
;;^UTILITY(U,$J,358.3,8687,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8687,1,3,0)
;;=3^Multiple Myeloma,In Relapse
;;^UTILITY(U,$J,358.3,8687,1,4,0)
;;=4^C90.02
;;^UTILITY(U,$J,358.3,8687,2)
;;=^5001753
;;^UTILITY(U,$J,358.3,8688,0)
;;=D51.9^^39^401^25
;;^UTILITY(U,$J,358.3,8688,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8688,1,3,0)
;;=3^Anemia in Vitamin B12 Deficiency
;;^UTILITY(U,$J,358.3,8688,1,4,0)
;;=4^D51.9
;;^UTILITY(U,$J,358.3,8688,2)
;;=^5002289
;;^UTILITY(U,$J,358.3,8689,0)
;;=C79.51^^39^401^35
;;^UTILITY(U,$J,358.3,8689,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0JA 3750 printed Apr 09, 2024@20:44:55 Page 2
IBDEI0JA ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8677,0)
+2 ;;=D68.0^^39^401^213
+3 ;;^UTILITY(U,$J,358.3,8677,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,8677,1,3,0)
+6 ;;=3^Von Willebrand's Disease
+7 ;;^UTILITY(U,$J,358.3,8677,1,4,0)
+8 ;;=4^D68.0
+9 ;;^UTILITY(U,$J,358.3,8677,2)
+10 ;;=^127267
+11 ;;^UTILITY(U,$J,358.3,8678,0)
+12 ;;=C88.0^^39^401^214
+13 ;;^UTILITY(U,$J,358.3,8678,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,8678,1,3,0)
+16 ;;=3^Waldenstrom Macroglobulinemia
+17 ;;^UTILITY(U,$J,358.3,8678,1,4,0)
+18 ;;=4^C88.0
+19 ;;^UTILITY(U,$J,358.3,8678,2)
+20 ;;=^5001748
+21 ;;^UTILITY(U,$J,358.3,8679,0)
+22 ;;=C91.02^^39^401^3
+23 ;;^UTILITY(U,$J,358.3,8679,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,8679,1,3,0)
+26 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
+27 ;;^UTILITY(U,$J,358.3,8679,1,4,0)
+28 ;;=4^C91.02
+29 ;;^UTILITY(U,$J,358.3,8679,2)
+30 ;;=^5001764
+31 ;;^UTILITY(U,$J,358.3,8680,0)
+32 ;;=C92.02^^39^401^6
+33 ;;^UTILITY(U,$J,358.3,8680,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,8680,1,3,0)
+36 ;;=3^Acute Myeloblastic Leukemia,In Relapse
+37 ;;^UTILITY(U,$J,358.3,8680,1,4,0)
+38 ;;=4^C92.02
+39 ;;^UTILITY(U,$J,358.3,8680,2)
+40 ;;=^5001791
+41 ;;^UTILITY(U,$J,358.3,8681,0)
+42 ;;=D09.3^^39^401^50
+43 ;;^UTILITY(U,$J,358.3,8681,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,8681,1,3,0)
+46 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
+47 ;;^UTILITY(U,$J,358.3,8681,1,4,0)
+48 ;;=4^D09.3
+49 ;;^UTILITY(U,$J,358.3,8681,2)
+50 ;;=^5001955
+51 ;;^UTILITY(U,$J,358.3,8682,0)
+52 ;;=C22.0^^39^401^91
+53 ;;^UTILITY(U,$J,358.3,8682,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,8682,1,3,0)
+56 ;;=3^Hepatocellular Carcinoma
+57 ;;^UTILITY(U,$J,358.3,8682,1,4,0)
+58 ;;=4^C22.0
+59 ;;^UTILITY(U,$J,358.3,8682,2)
+60 ;;=^5000933
+61 ;;^UTILITY(U,$J,358.3,8683,0)
+62 ;;=C24.9^^39^401^118
+63 ;;^UTILITY(U,$J,358.3,8683,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,8683,1,3,0)
+66 ;;=3^Malig Neop Biliary Tract,Unspec
+67 ;;^UTILITY(U,$J,358.3,8683,1,4,0)
+68 ;;=4^C24.9
+69 ;;^UTILITY(U,$J,358.3,8683,2)
+70 ;;=^5000942
+71 ;;^UTILITY(U,$J,358.3,8684,0)
+72 ;;=C50.922^^39^401^142
+73 ;;^UTILITY(U,$J,358.3,8684,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,8684,1,3,0)
+76 ;;=3^Malig Neop Left Male Breast,Unspec Site
+77 ;;^UTILITY(U,$J,358.3,8684,1,4,0)
+78 ;;=4^C50.922
+79 ;;^UTILITY(U,$J,358.3,8684,2)
+80 ;;=^5133340
+81 ;;^UTILITY(U,$J,358.3,8685,0)
+82 ;;=C34.91^^39^401^160
+83 ;;^UTILITY(U,$J,358.3,8685,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,8685,1,3,0)
+86 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
+87 ;;^UTILITY(U,$J,358.3,8685,1,4,0)
+88 ;;=4^C34.91
+89 ;;^UTILITY(U,$J,358.3,8685,2)
+90 ;;=^5000967
+91 ;;^UTILITY(U,$J,358.3,8686,0)
+92 ;;=C50.921^^39^401^164
+93 ;;^UTILITY(U,$J,358.3,8686,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,8686,1,3,0)
+96 ;;=3^Malig Neop Right Male Breast,Unspec Site
+97 ;;^UTILITY(U,$J,358.3,8686,1,4,0)
+98 ;;=4^C50.921
+99 ;;^UTILITY(U,$J,358.3,8686,2)
+100 ;;=^5001198
+101 ;;^UTILITY(U,$J,358.3,8687,0)
+102 ;;=C90.02^^39^401^176
+103 ;;^UTILITY(U,$J,358.3,8687,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,8687,1,3,0)
+106 ;;=3^Multiple Myeloma,In Relapse
+107 ;;^UTILITY(U,$J,358.3,8687,1,4,0)
+108 ;;=4^C90.02
+109 ;;^UTILITY(U,$J,358.3,8687,2)
+110 ;;=^5001753
+111 ;;^UTILITY(U,$J,358.3,8688,0)
+112 ;;=D51.9^^39^401^25
+113 ;;^UTILITY(U,$J,358.3,8688,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,8688,1,3,0)
+116 ;;=3^Anemia in Vitamin B12 Deficiency
+117 ;;^UTILITY(U,$J,358.3,8688,1,4,0)
+118 ;;=4^D51.9
+119 ;;^UTILITY(U,$J,358.3,8688,2)
+120 ;;=^5002289
+121 ;;^UTILITY(U,$J,358.3,8689,0)
+122 ;;=C79.51^^39^401^35
+123 ;;^UTILITY(U,$J,358.3,8689,1,0)
+124 ;;=^358.31IA^4^2
